1302 related articles for article (PubMed ID: 21963266)
1. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
[TBL] [Abstract][Full Text] [Related]
2. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
[TBL] [Abstract][Full Text] [Related]
3. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%.
Chia A; Chua WH; Wen L; Fong A; Goon YY; Tan D
Am J Ophthalmol; 2014 Feb; 157(2):451-457.e1. PubMed ID: 24315293
[TBL] [Abstract][Full Text] [Related]
4. Atropine for the treatment of childhood myopia.
Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
[TBL] [Abstract][Full Text] [Related]
5. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for progressive myopia in the atropine therapy for myopia study.
Loh KL; Lu Q; Tan D; Chia A
Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
[TBL] [Abstract][Full Text] [Related]
8. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Changes in Refraction and Biometry of Atropine- and Placebo-Treated Eyes.
Kumaran A; Htoon HM; Tan D; Chia A
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5650-5. PubMed ID: 26313301
[TBL] [Abstract][Full Text] [Related]
10. Atropine treatment for myopia.
Brown SM
Ophthalmology; 2009 Oct; 116(10):2040; author reply 2040-1. PubMed ID: 19800530
[No Abstract] [Full Text] [Related]
11. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
Yam JC; Li FF; Zhang X; Tang SM; Yip BHK; Kam KW; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2020 Jul; 127(7):910-919. PubMed ID: 32019700
[TBL] [Abstract][Full Text] [Related]
12. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.
Chia A; Lu QS; Tan D
Ophthalmology; 2016 Feb; 123(2):391-399. PubMed ID: 26271839
[TBL] [Abstract][Full Text] [Related]
13. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study.
Fan DS; Lam DS; Chan CK; Fan AH; Cheung EY; Rao SK
Jpn J Ophthalmol; 2007; 51(1):27-33. PubMed ID: 17295137
[TBL] [Abstract][Full Text] [Related]
14. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
Li FF; Kam KW; Zhang Y; Tang SM; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC
Ophthalmology; 2020 Dec; 127(12):1603-1611. PubMed ID: 32525048
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of 1% Atropine on Retardation of Moderate Myopia Progression in Chinese School Children.
Zhu Q; Tang Y; Guo L; Tighe S; Zhou Y; Zhang X; Zhang J; Zhu Y; Hu M
Int J Med Sci; 2020; 17(2):176-181. PubMed ID: 32038101
[No Abstract] [Full Text] [Related]
16. Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol.
Azuara-Blanco A; Logan N; Strang N; Saunders K; Allen PM; Weir R; Doherty P; Adams C; Gardner E; Hogg R; McFarland M; Preston J; Verghis R; Loughman JJ; Flitcroft I; Mackey DA; Lee SS; Hammond C; Congdon N; Clarke M
Br J Ophthalmol; 2020 Jul; 104(7):950-955. PubMed ID: 31653669
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tropicamide and cyclopentolate for cycloplegic refractions in myopic adult refractive surgery patients.
Hofmeister EM; Kaupp SE; Schallhorn SC
J Cataract Refract Surg; 2005 Apr; 31(4):694-700. PubMed ID: 15899444
[TBL] [Abstract][Full Text] [Related]
18. Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three-year results of a randomized clinical trial.
Cheng D; Woo GC; Drobe B; Schmid KL
JAMA Ophthalmol; 2014 Mar; 132(3):258-64. PubMed ID: 24435660
[TBL] [Abstract][Full Text] [Related]
19. Influences of cycloplegia with topical atropine on ocular higher-order aberrations.
Hiraoka T; Miyata K; Nakamura Y; Miyai T; Ogata M; Okamoto F; Oshika T
Ophthalmology; 2013 Jan; 120(1):8-13. PubMed ID: 23084238
[TBL] [Abstract][Full Text] [Related]
20. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial.
Yam JC; Zhang XJ; Zhang Y; Yip BHK; Tang F; Wong ES; Bui CHT; Kam KW; Ng MPH; Ko ST; Yip WWK; Young AL; Tham CC; Chen LJ; Pang CP
JAMA; 2023 Feb; 329(6):472-481. PubMed ID: 36786791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]